This inventor holds 4 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignee: Oncoarendi Therapeutics S.a.. Active years: 2019-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2024
Title: Karol Jedrzejczak: Innovator in Therapeutic Applications
Introduction
Karol Jedrzejczak is a notable inventor based in Lodz, Poland. He has made significant contributions to the field of therapeutic compounds, particularly in the area of arginase inhibitors. With a total of 4 patents to his name, his work is paving the way for advancements in medical treatments.
Latest Patents
Jedrzejczak's latest patents focus on arginase inhibitors and their therapeutic applications. These patents disclose small molecule therapeutic compounds that are potent inhibitors of arginase 1 and arginase 2 activity. Additionally, they include pharmaceutical compositions comprising these compounds, along with methods for using them to treat or prevent diseases associated with arginase activity.
Career Highlights
Karol Jedrzejczak is currently associated with Oncoarendi Therapeutics S.A., where he continues to innovate in the field of therapeutic applications. His work is instrumental in developing new treatments that could significantly impact patient care.
Collaborations
He collaborates with talented individuals such as Roman Blaszczyk and Anna Gzik, contributing to a dynamic research environment that fosters innovation.
Conclusion
Karol Jedrzejczak's contributions to the field of therapeutic compounds highlight his role as a leading inventor in the medical research community. His work on arginase inhibitors is set to make a lasting impact on the treatment of various diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile